COMPARISON OF PHARMACISTS PROFESSIONAL ACTIVITY OF UKRAINIAN PHARMACY ON PROVISION OF INFORMATION ON ADVERSE REACTIONS OF PHARMACEUTICAL PRODUCTS
Аннотация
The aim of the research is the comparison of professional activity of pharmacists of pharmaceutical institution in Ukraine with different education level in relation to their responsibilities in detection and prevention of adverse reactions (AR) or lack of efficacy of pharmaceutical products (PP), set out in the regulatory documentation on this matter.
Materials and methods. The questionnaire was developed and used for pharmacists of pharmaceutical institution, taken training on cycles of postgraduate education during 2016–2018. 70 higher education pharmacists (HEPs) and 80 specialized secondary education pharmacists (SSEP) were inquired. The integrity was evaluated by Fisher's ratio test (F). For convenience of calculation the corresponding functions of MS Excel were used.
Results. The majority of SSEPs and HEPs of Ukrainian pharmaceutical institutions are aware of their duty to provide information on AR or lack of efficacy of pharmaceutical products to the Department of Post-authorization Supervision of the State Expert Center of the Ministry of Health of Ukraine and are aware of the regulatory legal documentation on this issue, however they are not active enough to take necessary action filling in the “Adverse drug reaction reporting form” and sending it to the national department. One of the reasons for the underactivity of pharmacy workers, irrespective of their level of education, is the low organization of this process in pharmacy institutions, in particular the absence of the “Adverse drug reaction reporting forms”.
Conclusion. Higher education pharmacist are more self-acting in completing “Adverse drug reaction reporting forms” and are less likely to shift their responsibilities to the pharmacy manager. It is critical to resolve the issue on enhancement of efficiency of detecting AR and/or lack of efficacy of PP in pharmacy institutions of Ukraine is to improve the quality of organizational work of pharmacy managers.
Скачивания
Литература
Twentieth World Health Assembly (1967). Part I: resolutions and decisions: annexes. Geneva. Available at: http://apps.who.int/iris/bitstream/handle/10665/103437/Official_record160_rus.pdf Last accessed: 21.11.2019
Drug safety monitoring. Guidelines for the organization and functioning of pharmacovigilance centers. Available at: https://www.who-umc.org/media/1711/24750.pdf Last accessed: 21.11.2019
Attitude. Medical products. Good pharmacovigilance practices (2015). Ministry of Health of Ukraine. No. 299. 21.05.2015. Available at: http://moz.gov.ua/uploads/0/4417-dn_20180405_620.pdf
Dadyshyna, L. (2014). Pharmacovigilance as a complete component of the healthcare system. Pharmacist Practitioner, 10, 4–6.
Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services from the WHO technical report series, No. 961, 45th report of the WHO Expert Committee on specifications for pharmaceutical preparations (2011). World Health Organization. Available at: http://www.who.int/medicines/services/expertcommittees/pharmprep/CLEAN-Rev2Final-GPP-StandardsQ-PharmacyServices-QAS10-352_Sept2010.pdf Last accessed: 21.11.2019
On approval of the Pharmacovigilance Procedure (2006). Ministry of Health of Ukraine No. 898. 27.12.2006. Available at: https://zakon.rada.gov.ua/laws/main/z0073-07 Last accessed: 21.11.2019
On the approval of the protocols of the pharmacist (2013). Ministry of Health of Ukraine No. 875. 11.10.2013. Available at: https://zakon.rada.gov.ua/rada/show/v0875282-13 Last accessed: 21.11.2019
Mishchenko, O. Y., Ostashko, V. F., Kovalenko, E. N. (2018). Study of awareness of pharmacists about their work in the pharmacovigilance system in Ukraine and their professional activity. Farmatsevtychnyi Zhurnal, 3-4, 12–20. doi: http://doi.org/10.32352/0367-3057.3-4.18.03
Mishchenko, O. Y., Ostashko, V. F., Kovalenko, Y. M., Greshko, Y. I. (2019). Evaluation of the professional activity of pharmacists in pharmacies regarding their responsibilities in ensuring the safe use of medicines. Social Pharmacy in Health Care, 5 (2), 36–42. doi: http://doi.org/10.24959/sphhcj.19.150
Yevtushenko, O. M. (2013). The role of the pharmaceutical sales representative in monitoring the safety of medicines. Problems of environmental and medical genetics and clinical immunology, 5, 219–225.
Rudenko, V. M. (2012). Mathematical statistics. Kyiv: Learning Resource Center, 304.
Granas, A. G., Buajordet, M., Stenberg-Nilson, H., Harg, P., Horn, A. M. (2007). Pharmacists attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf, 16, 429–434. doi: http://doi.org/10.1002/pds.1298
Rajanandh, M. G., Praveen, K. V., Yuvasakthi, S. (2016). Roles of Pharmacist in Pharmacovigilance: A Need of the Hour. Journal of Pharmacovigilance, 4 (6). doi: http://doi.org/10.4172/2329-6887.1000221
Janaki, R. T., Rajesh, H. (2011). Pharmacovigilance. International Journal of Pharma and Bio Sciences, 2, 95–101.
Gavaza, P., Brown, C. M., Lawson, K. A., Rascati, K. L., Steinhardt, M., Wilson, J. P. (2012). Pharmacist reporting of serious adverse drug events to the Food and Drug Administration. Journal of the American Pharmacists Association, 52 (5), e109–e112. doi: http://doi.org/10.1331/japha.2012.11260
Barach, P. (2000). Reporting and preventing medical mishaps: lessons from non-medical near miss reporting systems. BMJ, 320 (7237), 759–763. doi: http://doi.org/10.1136/bmj.320.7237.759
Sweis, D., Wong, I. C. K. (2000). A Survey on Factors that Could Affect Adverse Drug Reaction Reporting According to Hospital Pharmacists in Great Britain. Drug Safety, 23 (2), 165–172. doi: http://doi.org/10.2165/00002018-200023020-00006
Aziz, Z., Siang, T. C., Badarudin, N. S. (2007). Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiology and Drug Safety, 16 (2), 223–228. doi: http://doi.org/10.1002/pds.1313
Bäckström, M., Mjörndal, T., Dahlqvist, R., Nordkvist-Olsson, T. (2000). Attitudes to reporting adverse drug reactions in northern Sweden. European Journal of Clinical Pharmacology, 56 (9-10), 729–732. doi: http://doi.org/10.1007/s002280000202
Vallano, A., Cereza, G., Pedròs, C., Agustí, A., Danés, I., Aguilera, C., Arnau, J. M. (2005). Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. British Journal of Clinical Pharmacology, 60 (6), 653–658. doi: http://doi.org/10.1111/j.1365-2125.2005.02504.x
Green, E. C. (2000). The WHO Forum on Traditional Medicine in Health Systems, Harare, Zimbabwe, February 14-18, 2000. The Journal of Alternative and Complementary Medicine, 6 (5), 379–382. doi: http://doi.org/10.1089/acm.2000.6.379
Copyright (c) 2020 Oksana Mishchenko, Vasiliy Ostashko, Iuliia Greshko
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Наше издание использует положения об авторских правах CREATIVE COMMONS для журналов открытого доступа.
Авторы, которые публикуются в этом журнале, соглашаются со следующими условиями:
1. Авторы оставляют за собой право на авторство своей работы и передают журналу право первой публикации этой работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим лицам свободно распространять опубликованную работу с обязательной ссылкой на авторов оригинальной работы и первую публикацию работы в этом журнале.
2. Авторы имеют право заключать самостоятельные дополнительные соглашения, которые касаются неэксклюзивного распространения работы в том виде, в котором она была опубликована этим журналом (например, размещать работу в электронном хранилище учреждения или публиковать в составе монографии), при условии сохранения ссылки на первую публикацию работы в этом журнале .
